DK2702159T3 - MODIFIED SENDAI VIRUS VACCINE AND IMAGE VECTOR - Google Patents

MODIFIED SENDAI VIRUS VACCINE AND IMAGE VECTOR Download PDF

Info

Publication number
DK2702159T3
DK2702159T3 DK12777657.3T DK12777657T DK2702159T3 DK 2702159 T3 DK2702159 T3 DK 2702159T3 DK 12777657 T DK12777657 T DK 12777657T DK 2702159 T3 DK2702159 T3 DK 2702159T3
Authority
DK
Denmark
Prior art keywords
virus
sendai virus
gene
infection
sendai
Prior art date
Application number
DK12777657.3T
Other languages
Danish (da)
English (en)
Inventor
Charles John Russell
Allen Portner
Toru Takimoto
Karen S Slobod
Julia Lea Hurwitz
Original Assignee
St Jude Childrens Res Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Jude Childrens Res Hospital filed Critical St Jude Childrens Res Hospital
Application granted granted Critical
Publication of DK2702159T3 publication Critical patent/DK2702159T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18821—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18834—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18841—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK12777657.3T 2011-04-28 2012-04-13 MODIFIED SENDAI VIRUS VACCINE AND IMAGE VECTOR DK2702159T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161480008P 2011-04-28 2011-04-28
PCT/US2012/033482 WO2012148708A1 (fr) 2011-04-28 2012-04-13 Vaccin de virus sendai modifié et vecteur d'imagerie

Publications (1)

Publication Number Publication Date
DK2702159T3 true DK2702159T3 (en) 2018-11-19

Family

ID=47072689

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12777657.3T DK2702159T3 (en) 2011-04-28 2012-04-13 MODIFIED SENDAI VIRUS VACCINE AND IMAGE VECTOR

Country Status (10)

Country Link
US (2) US9637758B2 (fr)
EP (1) EP2702159B1 (fr)
DK (1) DK2702159T3 (fr)
ES (1) ES2689797T3 (fr)
HR (1) HRP20181439T1 (fr)
LT (1) LT2702159T (fr)
PL (1) PL2702159T3 (fr)
PT (1) PT2702159T (fr)
TR (1) TR201815468T4 (fr)
WO (1) WO2012148708A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2702159T (lt) * 2011-04-28 2019-01-10 St. Jude Children`S Research Hospital Modifikuoto sendai viruso vakcina ir iliustratyvus vektorius
RU2552487C2 (ru) * 2013-10-31 2015-06-10 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Аттенуированный штамм вируса сендай
WO2016069518A2 (fr) * 2014-10-27 2016-05-06 International Aids Vaccine Initiative Vecteur(s) de type virus sendai génétiquement stable(s) compétent(s) pour la réplication contenant et exprimant des gènes du vih optimisés
JP7020917B2 (ja) 2015-01-20 2022-02-16 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ キメラｒｓｖ／ｂｐｉｖ３ ｆタンパクを発現する組換えヒト／ウシパラインフルエンザウイルス３（ｂ／ｈｐｉｖ３）およびその使用
CN109180821B (zh) * 2018-09-19 2021-10-15 天康制药(苏州)有限公司 鸡新城疫病毒的融合蛋白及其制备方法、应用和疫苗

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
WO1997016539A1 (fr) 1995-11-01 1997-05-09 Dnavec Research Inc. Virus sendai recombinant
CN1248740C (zh) 2000-03-30 2006-04-05 株式会社载体研究所 使用仙台病毒载体的aids病毒疫苗
CA2322057A1 (fr) 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus utilises comme vecteurs pour le transfert de genes etrangers
DE10026723B4 (de) 2000-05-30 2009-04-02 Krones Ag Maischgefäß
WO2001092548A2 (fr) 2000-06-01 2001-12-06 St. Jude Children's Research Hospital Vaccin, vecteur de therapie genique et procedes d'utilisation associes
CA2467958A1 (fr) 2001-11-21 2003-05-30 Brian R. Murphy Recuperation d'un virus parainfluenza de type 1 humain (hpiv1) a partir d'un adn complementaire et utilisation du hpiv1 recombinant dans des compositions immunogenes et comme vecteur pour induire des reponses immunitaires dirigees contre piv et d'autres agents pathogenes humains
US20060110740A1 (en) 2003-01-20 2006-05-25 Julia Hurwitz Use of sendai virus as a human parainfluenza vaccine
EP2123755A1 (fr) * 2007-02-07 2009-11-25 Dnavec Corporation Virus a arn a brin negatif attenue
JP4936482B2 (ja) * 2007-04-13 2012-05-23 独立行政法人産業技術総合研究所 改良された持続感染型センダイウイルスベクター
LT2702159T (lt) * 2011-04-28 2019-01-10 St. Jude Children`S Research Hospital Modifikuoto sendai viruso vakcina ir iliustratyvus vektorius

Also Published As

Publication number Publication date
US9637758B2 (en) 2017-05-02
EP2702159A4 (fr) 2015-03-25
EP2702159A1 (fr) 2014-03-05
HRP20181439T1 (hr) 2018-11-02
ES2689797T3 (es) 2018-11-15
WO2012148708A1 (fr) 2012-11-01
US20140186397A1 (en) 2014-07-03
LT2702159T (lt) 2019-01-10
US10329584B2 (en) 2019-06-25
EP2702159B1 (fr) 2018-07-25
PT2702159T (pt) 2018-10-30
TR201815468T4 (tr) 2018-11-21
PL2702159T3 (pl) 2019-03-29
US20170321224A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
US10329584B2 (en) Modified Sendai virus vaccine and imaging vector
Liniger et al. Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses
US9011876B2 (en) Live, attenuated respiratory syncytial virus
TW200930816A (en) Metapneumovirus strains as vaccine formulations and as vectors for expression of heterologous antigenic sequences
Burke et al. Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy
JP2011250798A5 (fr)
JP2012507302A5 (fr)
Liu et al. Hemagglutinin–Neuraminidase and fusion genes are determinants of NDV thermostability
Sawada et al. AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats
Takimoto et al. Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus
EP3923983A1 (fr) Protéines f chimériques de rsv et hmpv, compositions immunogènes, et méthodes d'utilisation
Tao et al. A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge
TWI419968B (zh) 多價嵌合型德國麻疹載體病毒疫苗
JP4814799B2 (ja) トランスに相補されたゲノム欠損を有する呼吸器合胞体ウイルス
Zhao et al. An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice
CA3215468A1 (fr) Virus chimerique de la maladie de newcastle exprimant des proteines hn et f d'apmv
TW202208399A (zh) 嵌合呼吸道合胞病毒(rsv)及冠狀病毒蛋白、免疫源性組合物及使用方法
Kiyotani et al. Attenuation of a field Sendai virus isolate through egg-passages is associated with an impediment of viral genome replication in mouse respiratory cells
Liu et al. Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live‐attenuated vaccine candidate in the mouse model
US20170080081A1 (en) Paramyxovirus Immunogens and Related Materials and Methods
CN116490515A (zh) 嵌合rsv和冠状病毒蛋白、免疫原性组合物和使用方法
Krishnamurthy et al. Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in...
CA3007474A1 (fr) Souches de virus respiratoires syncytiaux recombines comprenant des decalages des genes ns1 et ns2